Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chu

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Progress in Cardiovascular Diseases|February 2, 2025
Resting heart rate - The forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and EuropeChi Pang Wen, Chien Hua Chen, Javaid Nauman, et al.
The Journal of Infectious Diseases|January 3, 2006
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experienceJohn V Williams, Chiaoyin K Wang, Chin-Fen Yang, et al.
Journal of Pediatric Urology|July 19, 2020
A survey and panel discussion of the effects of the COVID-19 pandemic on paediatric urological productivity, guideline adherence and provider stressFardod O'Kelly, Scott Sparks, Casey Seideman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
Oncotarget|February 21, 2022
<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer modelKaren Cravero, Morgan V Pantone, Dong Ho Shin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stabilitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Progress in Cardiovascular Diseases|February 2, 2025
Resting heart rate - The forgotten risk factor? Comparison of resting heart rate and hypertension as predictors of all-cause mortality in 692,217 adults in Asia and EuropeChi Pang Wen, Chien Hua Chen, Javaid Nauman, et al.
The Journal of Infectious Diseases|January 3, 2006
The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experienceJohn V Williams, Chiaoyin K Wang, Chin-Fen Yang, et al.
Journal of Pediatric Urology|July 19, 2020
A survey and panel discussion of the effects of the COVID-19 pandemic on paediatric urological productivity, guideline adherence and provider stressFardod O'Kelly, Scott Sparks, Casey Seideman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
Breast Cancer Research and Treatment|December 19, 2018
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapiesBerry Button, Sarah Croessmann, David Chu, et al.
Oncotarget|February 21, 2022
<i>NOTCH1</i> PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer modelKaren Cravero, Morgan V Pantone, Dong Ho Shin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stabilitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
The Journal of Clinical Investigation|February 2, 2021
Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclonesSwathi Karthikeyan, Ian G Waters, Lauren Dennison, et al.
Oncotarget|February 3, 2017
Detection fidelity of AR mutations in plasma derived cell-free DNAAlexa Goldstein, Patricia Valda Toro, Justin Lee, et al.
Pageof 12